Need a specific person's email?
Browse Mapp Biopharmaceutical Inc's employee directory (about 73 employees) and reveal verified emails free.
Mapp Biopharmaceutical Inc's most common email format is First.Last@mappbio.com (ex. John.Doe@mappbio.com), used for 94% of mappbio.com addresses. Mapp Biopharmaceutical Inc uses 4 email patterns.
| Format | Example | Share of mappbio.com |
|---|---|---|
| First.Last@mappbio.comMost common | John.Doe@mappbio.com | |
| FLast@mappbio.com | JDoe@mappbio.com | |
| Last@mappbio.com | Doe@mappbio.com | |
| Fir.Last@mappbio.com | Joh.Doe@mappbio.com |
Browse Mapp Biopharmaceutical Inc's employee directory (about 73 employees) and reveal verified emails free.
Biotechnology ResearchCalifornia, United States51-200 Employees
Mapp Biopharmaceutical, Inc. is a mid-sized biotechnology company based in San Diego, California. It focuses on developing monoclonal antibody therapies to address neglected infectious diseases. The company's work centers on advancing antibody-based treatments that could fill gaps where limited approved options exist. It maintains an expanded access program to provide investigational products to eligible patients with documented disease or high-risk exposure, under physician oversight. The firm is actively developing MBP-134, a pan-ebolavirus monoclonal antibody therapy. In May 2026, Mapp announced a collaboration with Medical Countermeasures to facilitate access to MBP-134 for potential use in high-risk individuals.
Most common format
First.Last@mappbio.com
Example: John.Doe@mappbio.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.